MOTS-c: Mitochondrial-Derived Peptide Research

Compiled by the APL Research TeamSourced directly from peer-reviewed pharmacological literature and clinical guidelines.

Key Takeaways

• Expert Insight: An overview of MOTS-c, a mitochondrial-derived peptide encoded by the 12S rRNA gene, covering its role in AMPK activation, metabolic regulation, exercise mimicry, and ageing research.
• Quality Assurance: All discussed methodologies align with stringent Australian laboratory standards.
• Clinical Relevance: Critical informational resource for verifying the stability and purity of mots-c: mitochondrial-derived peptide research in-vitro.

Introduction

MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically within the 12S ribosomal RNA gene. Discovered in 2015 by Changhan David Lee and Pinchas Cohen at the University of Southern California, MOTS-c was the first mitochondrial-derived peptide (MDP) shown to act as a systemic signalling molecule, challenging the traditional view of mitochondria as purely energy-producing organelles.

The discovery that mitochondria encode bioactive peptides with hormonal functions has opened an entirely new area of biology: mitochondrial-derived peptide signalling, sometimes called "mitochondrial endocrinology."

Molecular Profile

Mitochondrial-Derived Peptides: A New Class

MOTS-c belongs to the mitochondrial-derived peptide family, which includes:

These peptides are encoded as short open reading frames (sORFs) within mitochondrial rRNA genes — sequences previously considered non-coding. Their discovery illustrates how the mitochondrial genome, despite containing only 37 genes, can produce a wider array of bioactive molecules than previously recognised.

Mechanism of Action

AMPK Activation

The primary established mechanism of MOTS-c is activation of 5' AMP-activated protein kinase (AMPK), the master cellular energy sensor:

1. Folate-methionine cycle disruption — MOTS-c inhibits the folate cycle, specifically targeting the enzyme MTHFD2 (methylenetetrahydrofolate dehydrogenase 2)
2. AICAR accumulation — inhibition of the folate cycle leads to accumulation of the purine biosynthesis intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide)
3. AICAR activates AMPK — AICAR is a well-established endogenous AMPK activator, mimicking AMP binding to the gamma subunit
4. Downstream AMPK effects — activated AMPK triggers a cascade of metabolic adaptations

AMPK Downstream Effects

AMPK activation by MOTS-c produces metabolic changes that overlap significantly with exercise adaptations:

• Glucose uptake — AMPK stimulates GLUT4 translocation to the cell membrane, increasing glucose uptake independently of insulin
• Fatty acid oxidation — AMPK phosphorylates and inhibits ACC (acetyl-CoA carboxylase), reducing malonyl-CoA and de-repressing CPT1, increasing mitochondrial fatty acid import and oxidation
• Mitochondrial biogenesis — AMPK activates PGC-1α (via SIRT1), the master regulator of mitochondrial biogenesis and oxidative metabolism
• Inhibition of lipogenesis — AMPK suppresses SREBP-1c and other lipogenic transcription factors
• Autophagy induction — AMPK activates ULK1, initiating autophagy (cellular recycling)

Nuclear Translocation

A remarkable finding is that MOTS-c, despite being produced in mitochondria, can translocate to the nucleus:

• Under metabolic stress, MOTS-c accumulates in the nucleus
• Nuclear MOTS-c regulates adaptive gene expression, particularly antioxidant response element (ARE) genes
• This represents a form of mitochondria-to-nucleus retrograde signalling
• The nuclear translocation appears to be stress-responsive, increasing under conditions of oxidative or metabolic challenge

Key Research Findings

Exercise Mimicry

One of the most striking aspects of MOTS-c research is its overlap with exercise physiology:

• MOTS-c levels increase in skeletal muscle and plasma during exercise in both rodent and human studies
• Administration of MOTS-c to sedentary mice improved exercise capacity (running endurance) without training
• The metabolic adaptations (increased glucose uptake, enhanced fatty acid oxidation, mitochondrial biogenesis) mirror those produced by endurance exercise
• MOTS-c has been termed an "exercise-mimetic peptide" based on these findings

Metabolic Regulation

Animal studies have demonstrated broad metabolic effects:

• Prevention of diet-induced obesity in mice fed a high-fat diet
• Improved glucose tolerance and insulin sensitivity in diet-induced obesity models
• Reduced hepatic fat accumulation (consistent with enhanced fatty acid oxidation)
• Improved metabolic parameters in aged mice, partially reversing age-related metabolic decline

Ageing Research

MOTS-c has attracted significant attention in ageing research:

• Endogenous MOTS-c levels decline with age in both rodents and humans
• Administration of MOTS-c to aged mice improved physical capacity and metabolic health markers
• The decline in MOTS-c parallels the decline in mitochondrial function and metabolic flexibility that characterises ageing
• MOTS-c-treated aged mice showed improved skeletal muscle function, including increased grip strength and running endurance

Genetic Studies

Human genetic studies have identified MOTS-c variants associated with longevity:

• A naturally occurring variant (m.1382A>C, producing a K14Q substitution) is found at higher frequency in Japanese centenarians compared to controls
• This variant has been termed the "longevity-associated MOTS-c variant"
• Functional studies suggest the variant may have enhanced biological activity, though the mechanism is still under investigation
• Population studies across different ethnic groups are exploring whether other MOTS-c variants correlate with metabolic health or lifespan

Immune Function

Emerging research has identified immunomodulatory roles:

• MOTS-c enhances T cell activation and function under metabolic stress conditions
• The peptide improves T cell antigen-specific responses by regulating cellular metabolism (shifting to oxidative phosphorylation)
• These findings suggest a link between mitochondrial signalling and adaptive immunity

MOTS-c and the Exercise-Ageing Connection

One framework for understanding MOTS-c is as a molecular mediator connecting exercise, metabolism, and ageing:

1. Exercise → increases MOTS-c production → activates AMPK → metabolic adaptations
2. Ageing → reduced MOTS-c levels → decreased AMPK signalling → metabolic decline
3. Exogenous MOTS-c → restores AMPK activation → partially reverses age-related metabolic dysfunction

This framework positions MOTS-c as a potential mechanistic link explaining why exercise is protective against age-related metabolic diseases.

Research Considerations

MOTS-c is supplied as a lyophilised white powder. The 16-amino acid sequence contains both hydrophobic (Met, Trp, Ile, Phe, Tyr, Pro, Leu) and charged (Arg, Glu, Lys) residues, making it reasonably soluble in aqueous media.

Reconstitution: Use bacteriostatic water following standard protocols — see Reconstitution Best Practices.

Storage: -20°C for lyophilised material; 2-8°C after reconstitution. MOTS-c contains Trp and Met residues, making it susceptible to both photo-oxidation and methionine oxidation. Protect from light and store under inert conditions where possible. See Peptide Storage and Stability for detailed guidance.

Research considerations: Dose-response relationships for MOTS-c in animal models are still being characterised, and effects have not been established in humans.

All research involving MOTS-c should be conducted in accordance with institutional protocols. This compound is designated for laboratory research use only.

Mitochondrial-derived peptides are a young enough field that batch documentation is worth reading rather than filing. Every MOTS-c batch certificate publishes the chromatogram, peak list and identity confirmation for the lot it covers.

Frequently Asked Questions

Is MOTS-c legal to buy and research in Australia? MOTS-c is supplied strictly as a research chemical for in-vitro laboratory use. It is not approved for human therapeutic use in Australia and is not for human or animal consumption. Researchers are responsible for compliance with Therapeutic Goods Administration (TGA) regulations and their institution's protocols.

What is MOTS-c and what is it studied for? MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded within the 12S rRNA gene. In preclinical research it has been studied for AMPK activation, metabolic regulation (glucose uptake and fatty-acid oxidation), 'exercise-mimetic' adaptations, and age-related metabolic decline. These are laboratory findings only and do not establish any effect in humans.

How is the purity of MOTS-c verified? Every batch is analysed in-house by HPLC and mass spectrometry and ships with a Certificate of Analysis. Select batches also undergo independent, third-party purity verification.

How should MOTS-c be stored and reconstituted? MOTS-c ships as a lyophilised white powder. Reconstitute with bacteriostatic water, store lyophilised material at -20°C and reconstituted solution at 2-8°C. Because the sequence contains tryptophan and methionine residues it is susceptible to photo- and methionine oxidation, so protect it from light and minimise air exposure.

Does Australian Peptide Labs provide MOTS-c dosing protocols? No. As these compounds are supplied for laboratory research only, we do not provide dosing or administration protocols. Our research library covers reconstitution and concentration calculations for in-vitro work.

References

1. Lee, C. et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance." Cell Metabolism, 2015. — PubMed: 25738459
2. Kim, K.H. et al. "The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress." Cell Metabolism, 2018. — PubMed: 29983246
3. Reynolds, J.C. et al. "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis." Nature Communications, 2021. — PubMed: 33473109
4. Zempo, H. et al. "A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c." Aging, 2021. — PubMed: 33468709

⚠️ Medical & Regulatory Disclaimer:
The information provided in this academic article is intended exclusively for educational and laboratory research purposes. It does NOT constitute medical advice. Compounds discussed are strictly for in-vitro research and development only, and are not intended for human consumption, veterinary use, or clinical treatment. Always adhere to Australian Therapeutic Goods Administration (TGA) regulations and your institution's ethical guidelines when handling research chemicals.